Sonnest, Inc.

📍 Baltimore, United States👥 11 employees💰 Last funded Jan 2021
Medical Equipment Manufacturing🌐 sonnest.com
Website LinkedIn
Sonnest, Inc. is pre-clinical healthcare company developing Electrast™, an ultrasound imaging drug that circulates through the body in the inactive state (dark on ultrasound) and is selectively activated (turned on) in the myocardium. With Electrast™ doctors will be able to evaluate perfusion of the heart quickly and cost-effectively at the point of care without exposure to ionizing radiation or toxic dies. The technology was developed by a talented team of cardiologists and chemical engineers at Drexel University with grant funding from the Coulter-Drexel Program and the inventors partnered with a team of successful serial healthcare entrepreneurs who have worked together for over 15 years across multiple companies to form Sonnest.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Sonnest, Inc.?
Sonnest, Inc. has 1 investors on record on gritt.io.
When did Sonnest, Inc. last raise funding?
The most recent investment in Sonnest, Inc. recorded on gritt.io was in January 2021.
What industry is Sonnest, Inc. in?
Sonnest, Inc. operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Sonnest, Inc. based?
Sonnest, Inc. is headquartered in Baltimore, United States.